LUFYLLIN Drug Patent Profile
✉ Email this page to a colleague
When do Lufyllin patents expire, and what generic alternatives are available?
Lufyllin is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in LUFYLLIN is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUFYLLIN?
- What are the global sales for LUFYLLIN?
- What is Average Wholesale Price for LUFYLLIN?
Summary for LUFYLLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 3,310 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LUFYLLIN at DailyMed |
US Patents and Regulatory Information for LUFYLLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Speciality Lp | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |